Related Experiment Video
Updated: Jul 13, 2026

04:46
Changing the Direction and Orientation of Electric Field During Electric Pulses Application Improves Plasmid Gene Transfer in vitro
Published on: September 12, 2011
Sine-wave current for efficient and safe in vivo gene transfer
Summary
Alternating current sine-wave electroporation safely enhances gene transfer in muscles, showing tenfold efficiency and reduced toxicity compared to traditional methods. This advance offers a promising approach for gene therapy applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Electrogen-gene transfer enhances gene expression, particularly in muscle.
- Conventional direct current (DC) square-wave electroporation exhibits toxicity due to high field strengths.
- Minimizing toxicity is crucial for routine clinical application of electroporation.
Purpose of the Study:
- To evaluate the safety and efficiency of alternating current sine-wave (ACSW) pulses for in vivo gene transfer.
- To compare ACSW electroporation with conventional DC square-wave pulses regarding efficiency and toxicity.
- To assess the potential of ACSW pulses for therapeutic protein delivery.
Main Methods:
- In vivo gene transfer in muscle using alternating current sine-wave (ACSW) pulses at 60 Hz and 20 V/cm.
- Comparison of ACSW pulses with conventional DC square-wave pulses.
- Delivery of human clotting factor IX (hFIX) plasmid into muscle via ACSW electroporation.
Main Results:
- ACSW pulses achieved efficient in vivo gene transfer with significantly reduced toxicity.
- Muscle gene transfer efficiency increased more than tenfold compared to DC square-wave pulses.
- Successful phenotypic correction was observed in hemophilia B mice following hFIX gene transfer.
Conclusions:
- Alternating current sine-wave electroporation is a safe and highly efficient method for muscle gene transfer.
- ACSW pulses offer a less toxic alternative to conventional DC square-wave electroporation.
- This technique holds promise for advancing gene therapy, including the treatment of hemophilia B.

